Lynparza 150 mg film-coated tablets, Lynparza 100 mg film-coated tablets
PASSION
Phase 2 small_molecule active
Quick answer
Lynparza 150 mg film-coated tablets, Lynparza 100 mg film-coated tablets for Patients with metastatic PDAC, who have not progressed following completion of at least 16 weeks (can be more) of any multiagent first-line chemotherapy is a Phase 2 program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Verona Pharma Ireland Limited
- Indication
- Patients with metastatic PDAC, who have not progressed following completion of at least 16 weeks (can be more) of any multiagent first-line chemotherapy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active